EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of Glucose Metabolizing Properties of Enterobacterial Probiotic Strains In Vitro

Jules Balanche iD, Emilie Lahaye iD, Lisa Bremard iD, Benjamin Thomas iD, Sergueï O Fetissov iD

Nutrients · 2024

DOI: 10.3390/nu16162677 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Nutrients, 2024. Verfasst von Jules Balanche und 4 weiteren Autor:innen. Beteiligte Einrichtung: Regulatory Peptides-Energy Metabolism and Motivated Behavior Team, Neuroendocrine, Endocrine and Germinal Differentiation and Communication Laborator…. Hauptthemen laut MEDLINE: Probiotics, Glucose. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PTM-2 Transversal Microbiota Program of Inserm, France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Before the absorption in the intestine, glucose encounters gut bacteria, which may serve as a barrier against hyperglycemia by metabolizing glucose. In the present study, we compared the capacity of enterobacterial strains to lower glucose levels in an in vitro model of nutrient-induced bacterial growth. Two probiotic strains, Hafnia alvei HA4597 (H. alvei) and Escherichia coli (E. coli) Nissle 1917, as well as E. coli K12, were studied. To mimic bacterial growth in the gut, a planktonic culture was supplemented twice daily by the Luria Bertani milieu with or without 0.5% glucose. Repeated nutrient provision resulted in the incremental growth of bacteria. However, in the presence of glucose, the maximal growth of both strains of E. coli but not of H. alvei was inhibited. When glucose was added to the culture medium, a continuous decrease in its concentration was observed during each feeding phase. At its highest density, H. alvei displayed more efficient glucose consumption accompanied by a more pronounced downregulation of glucose transporters’ expression than E. coli K12. Thus, the study reveals that the probiotic strain H. alvei HA4597 is more resilient to maintain its growth than E. coli in the presence of 0.5% glucose accompanied by more efficient glucose consumption. This experimental approach offers a new strategy for the identification of probiotics with increased glucose metabolizing capacities potentially useful for the prevention and co-treatment of type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsGlucoseEscherichia coliHafnia alveiEscherichia coli K12

Stichwörter der Autor:innen

bacterial glucose transportersglucose metabolismgut microbiotaprobioticstype 2 diabetes

Substanzen

Glucose

Autor:innen und Institutionen

  • Regulatory Peptides-Energy Metabolism and Motivated Behavior Team, Neuroendocrine, Endocrine and Germinal Differentiation and Communication Laboratory, Inserm UMR1239, University of Rouen Normandie, 76000 Rouen, France.

ORCID-Profile: Jules Balanche, Emilie Lahaye, Lisa Bremard, Benjamin Thomas, Sergueï O Fetissov

Förderung

  • PTM-2 Transversal Microbiota Program of Inserm, France

Zitieren

APA

Balanche, J., Lahaye, E., Bremard, L., Thomas, B., & Fetissov, S. O. (2024). Comparison of Glucose Metabolizing Properties of Enterobacterial Probiotic Strains In Vitro. Nutrients. https://doi.org/10.3390/nu16162677

Vancouver

Balanche J, Lahaye E, Bremard L, Thomas B, Fetissov SO. Comparison of Glucose Metabolizing Properties of Enterobacterial Probiotic Strains In Vitro. Nutrients. 2024. doi:10.3390/nu16162677

BibTeX
@article{Balanche2024,
  author = {Balanche, Jules and Lahaye, Emilie and Bremard, Lisa and Thomas, Benjamin and Fetissov, Sergueï O},
  title = {Comparison of Glucose Metabolizing Properties of Enterobacterial Probiotic Strains In Vitro},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16162677}
}
Kostenlos starten →